Patent ID: 8410127

Claim:
A crystalline salt of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine selected from the group consisting of: besylate salt, which has substantially the same X-ray power diffraction (XRPD) pattern as shown in FIG. 15 ; camsylate salt, which has substantially the same X-ray power diffraction (XRPD) pattern as shown in FIG. 16 ; esylate salt, which has substantially the same X-ray power diffraction (XRPD) pattern as shown in FIG. 17 ; HBr salt, which has substantially the same X-ray power diffraction (XRPD) pattern as shown in FIG. 18 ; sulfate salt, which has substantially the same X-ray power diffraction (XRPD) pattern as shown in FIG. 20 ; tosylate salt, which has substantially the same X-ray power diffraction (XRPD) pattern as shown in FIG. 21 ; and HCl salt, which has substantially the same X-ray power diffraction (XRPD) pattern as shown in FIG. 22 .